Although not a typical claim that the experts were badly selected, or were not competent, D’Angelo v Kujawski 2024 NY Slip Op 05200 Decided on October 23, 2024
Appellate Division, Second Department is really about experts. The case was decided on an analysis of the opposing experts in the underlying medical malpractice case.
“The plaintiff commenced this action against Mark C. Kujawski, Kujawski & Kujawski (hereinafter the Kujawski firm, and together with Mark C. Kujawski, the defendants), and another defendant to recover damages for legal malpractice. The plaintiff alleged, inter alia, that an SF-95 form prepared by the Kujawski firm on her behalf in connection with a medical malpractice action that she filed pro se in the United States District Court for the Eastern District of New York on behalf of her deceased son (hereinafter the decedent) was inadequate because the SF-95 form made no reference to medication as a contributing factor in the decedent’s death. After issue was joined in this action, the plaintiff moved for summary judgment on the issue of liability based upon the affirmation of her medical expert who opined that the decedent’s death was caused by a “narcotic-type overdose, which led to progressive respiratory depression.” The defendants cross-moved for summary judgment dismissing the amended complaint insofar as asserted against them, submitting, among other things, an affidavit and an affirmation of two physicians, both of whom examined the decedent’s medical records and reached a contrary conclusion to the plaintiff’s expert. In an order dated January 14, 2021, the Supreme Court, inter alia, granted the defendants’ cross-motion. The plaintiff appeals.
The defendants established, prima facie, that the plaintiff could not have prevailed in the underlying medical malpractice action based upon the opinions of their two experts. The defendants’ experts opined that Zofran, which was administered to the decedent before his death, did not contribute to the decedent’s death. The defendants’ experts further opined that the decedent suffered from multiple ailments, including chronic pain syndrome, spent most of his time in bed, and was on “long-term opiate therapy” for his pain condition, which rendered him highly tolerant of both fentanyl and oxycodone. One of the defendants’ experts averred that the plaintiff had been “receiving exactly the same dose and timing of both fentanyl and oxycodone that he [had been] taking outside of the hospital” for many years. The defendants’ experts further noted that the administration of Narcan when the decedent coded was not evidence that he was suffering from a drug overdose, since a patient in cardiac and/or respiratory arrest will commonly be given Narcan just in case narcotics are contributing to his or her condition as Narcan does no harm. Therefore, the defendants established, prima facie, that the plaintiff’s claims in the underlying medical malpractice action were not viable based upon proof that the decedent’s condition was not the result of an overdose of narcotic drugs.
In opposition, the plaintiff failed to raise a triable issue of fact. The plaintiff’s expert never attempted to refute the opinion of the defendants’ experts that Zofran did not contribute to the decedent’s death. Further, the plaintiff’s expert never addressed the contention of the defendants’ experts that patients who have been prescribed opiates are given Narcan if they go into coronary pulmonary arrest just in case the opiates are contributing to the condition since Narcan does no harm. Since the plaintiff’s expert failed to address the specific assertions of the defendants’ experts, the plaintiff failed to raise a triable issue of fact as to whether the plaintiff had viable claims in the underlying medical malpractice action (see Scopelliti v Westmed Med. Group, 193 AD3d 1009, 1011).
Accordingly, since the opinion of the plaintiff’s expert that the plaintiff had a viable claim was “conclusory in nature and not supported by available facts,” and was not sufficient to rebut the defendants’ prima facie showing that the plaintiff could not have prevailed in the underlying medical malpractice action, the Supreme Court properly granted the defendants’ cross-motion for summary judgment dismissing the amended complaint insofar as asserted against them.”